Pulmonary Circulation
Overview
Pulmonary Circulation is a peer-reviewed journal dedicated to advancing knowledge and understanding of the pulmonary circulation system. It publishes high-quality research articles, reviews, and case reports that explore various aspects of pulmonary vascular biology, pathophysiology, and clinical management. The journal serves as a valuable resource for researchers, clinicians, and healthcare professionals interested in respiratory medicine and cardiovascular health.
Details
Details
Abbr.
Pulm Circ
Publisher
Wiley
Start
2011
End
Continuing
Frequency
Quarterly
p-ISSN
2045-8932
e-ISSN
2045-8940
Country
United States
Language
English
Specialty
Pulmonary Medicine
Metrics
Metrics
h-index / Ranks: 6817
54
SJR / Ranks: 5662
761
CiteScore / Ranks: 6699
4.00
JIF / Ranks: 4138
2.6
Recent Articles
1.
Kim H, Gupta R, Rali P
Pulm Circ
. 2025 Mar;
15(1):e70056.
PMID: 40071063
Pulmonary embolism (PE) is a leading cause of mortality in lung transplant recipients, with early cases associated with particularly poor outcomes. Identified risk factors include elevated BMI, renal dysfunction, ABO...
2.
Rodriguez J, Zhang H, Mesfin N, Klings E, Lui J
Pulm Circ
. 2025 Mar;
15(1):e70021.
PMID: 40071062
To study the contribution of QRS prolongation to transplant-free survival, we conducted an observational study of 68 patients with sarcoidosis-related pulmonary hypertension. Every 10-ms increase in QRS interval was associated...
3.
Kholdani C, Lee J, Swenson K, Liu J, Hsi A, Kudelko K, et al.
Pulm Circ
. 2025 Mar;
15(1):e70063.
PMID: 40034146
Benchmarks of clinical management are essential for improving the quality of care. However, the lack of established quality metrics for pulmonary arterial hypertension (PAH) contributes to practice heterogeneity. We assessed...
4.
Hamilton G, Fletcher L, Harley W, Azzopardi R, Chan R, Fulcher J, et al.
Pulm Circ
. 2025 Feb;
15(1):e70053.
PMID: 40017790
Direct Fick (DF) and bolus thermodilution (TD) are endorsed by pulmonary hypertension (PH) guidelines to measure cardiac output. In contemporary practice, agreement between methods is unknown, as are the diagnostic...
5.
Robbins I, Hemnes A
Pulm Circ
. 2025 Feb;
15(1):e70059.
PMID: 40013009
Epoprostenol is a prostaglandin that was first identified by investigators in 1976 and found to be a potent vasodilator and inhibiter of platelet aggregation, initially in animal studies and subsequently...
6.
Sivakumar N, Zhang C, Chang-Chien C, Gu P, Li Y, Yang Y, et al.
Pulm Circ
. 2025 Feb;
15(1):e70057.
PMID: 39990646
Although right ventricle (RV) dysfunction drives clinical worsening in pulmonary hypertension (PH), information about RV function has not been well integrated in PH risk assessment. The gold standard for assessing...
7.
8.
Palevsky H, Butrous G, Elliott C
Pulm Circ
. 2025 Feb;
15(1):e70061.
PMID: 39980709
No abstract available.
9.
Morgan C, Woolfall K, Aikman N, Gale C, Subhedar N
Pulm Circ
. 2025 Feb;
15(1):e70052.
PMID: 39980708
Pulmonary hypertension (PH) in newborn babies is a relatively rare, heterogeneous condition that has high associated mortality in the neonatal period and beyond. There are limited evidence-based strategies to treat...
10.
Cai Y, Yan L, Cogan J, Hedges L, Nunley B, Negretti N, et al.
Pulm Circ
. 2025 Feb;
15(1):e70058.
PMID: 39980707
Transcription factor rare variants associate with pulmonary arterial hypertension (PAH), particularly in children, and are the second most common cause of heritable PAH. However, TBX4's down-stream targets and the molecular...